biostudies-literatureUnknown6Bohle FRecently, the European Commission (EC) published a regulatory proposal on plants generated with new genomic techniques (NGTs) (5 July 2023). According to this proposal, NGT plant applications are categorized into category 1 NGT (NGT1) and category 2 NGT (NGT2) based on their molecular characteristics, which diverges from the current legislation centered around Directive 2001/18/EC. To demonstrate where the path of the proposal leads to in practice, we applied the proposed criteria for categorization to a list of NGT plant applications currently in the commercialization pipeline. Combining literature research and a descriptive statistical approach, we can show that 94% of the plant applications affected by the EC proposal, would be classified as NGT1 and thus would receive market approval wFrontiers in genome editing1377117https://www.ebi.ac.uk/biostudies/studies/S-EPMC10973156biostudies-literatureWhere does the EU-path on new genomic techniques lead us?PMC10973156Schneider REngelhard MBohle FMundorf JZuhl LSimon SfalseWhere does the EU-path on new genomic techniques lead us?Recently, the European Commission (EC) published a regulatory proposal on plants generated with new genomic techniques (NGTs) (5 July 2023). According to this proposal, NGT plant applications are categorized into category 1 NGT (NGT1) and category 2 NGT (NGT2) based on their molecular characteristics, which diverges from the current legislation centered around Directive 2001/18/EC. To demonstrate where the path of the proposal leads to in practice, we applied the proposed criteria for categorization to a list of NGT plant applications currently in the commercialization pipeline. Combining literature research and a descriptive statistical approach, we can show that 94% of the plant applications affected by the EC proposal, would be classified as NGT1 and thus would receive market approval w2024-01-01T00:00:00Z20242025-04-26T11:19:12.596Z2025-04-06T13:41:36.664ZS-EPMC109731563855057010.3389/fgeed.2024.1377117